Revium Rx (RVRC) Non-Current Assets (2024 - 2025)
Revium Rx's (RVRC) quarterly Non-Current Assets came in at $5.2 million in Q4 2025, down 64.77% year-on-year from $14.8 million in Q4 2024, and down 64.77% quarter-over-quarter from $14.8 million in Q4 2024.
Revium Rx (RVRC) Non-Current Assets (2024 - 2025) Analysis & Trends
Revium Rx has disclosed Non-Current Assets across 2 years of filings, most recently posting $5.2 million for Q4 2025.
- Non-Current Assets for Q4 2025 came in at $5.2 million, down 64.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.2 million (down 64.77% YoY), and the FY2025 annual result was $5.2 million, down 64.77% from the prior year.
- Non-Current Assets came in at $5.2 million for Q4 2025 at Revium Rx, down from $14.8 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $14.8 million in Q4 2024 to a low of $5.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.07 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.52 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 2.84 Bn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 188.72 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 346.03 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 179.42 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 5.45 Bn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 451.87 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 1.28 Bn |
| 10 | Revium Rx | - | - | - | 5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | 14.77 Mn |